Russell Reynolds Associates Hires Bob Brousseau
Russell Reynolds Associates, a global search and leadership advisory firm, announced that Bob Brousseau has joined the firm's Healthcare Practice. Based in Dallas, Brousseau advises C-suite–level executive and management teams in the medical devices and diagnostics industries.
"With over three decades of experience in the clinical laboratory, pharmaceutical, drug device and diagnostics space, Bob's deep roster of executive connections and keen understanding of the regulatory environment make him uniquely qualified to advise our clients," said Constantine Alexandrakis, leader of Russell Reynolds Associates' Americas Region. "Our clients will also benefit from Bob's therapeutics expertise as well as his product launch experience that spans the full range of healthcare."
Prior to joining Russell Reynolds Associates, Brousseau was General Manager and Senior Vice President of Clinical Laboratory Testing at Veridia Diagnostics. In this role, he led the commercial and operational turnaround of the business. Previously, Brousseau held senior sales roles for Agendia, Genoptix, Cypress Bioscience and Verus Pharmaceuticals in California and the Center for Disease Detection in Texas. He began his career by spending nearly 10 years at Elan Pharmaceuticals.
Brousseau holds a BBA in finance from the University of Oklahoma and an MBA from Southern Methodist University in Dallas.